Michael Conroy

775 total citations · 1 hit paper
19 papers, 464 citations indexed

About

Michael Conroy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Conroy has authored 19 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in Michael Conroy's work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (3 papers) and Lung Cancer Research Studies (2 papers). Michael Conroy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (3 papers) and Lung Cancer Research Studies (2 papers). Michael Conroy collaborates with scholars based in United States, Ireland and Belgium. Michael Conroy's co-authors include Jarushka Naidoo, Sophie Lucas, Vanessa Zaiatz-Bittencourt, David K. Finlay, John Kennedy, Karen Slattery, Clair M. Gardiner, Austin G. Duffy, Walter Kölch and Tabitha G. Moe and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Michael Conroy

18 papers receiving 457 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immune-related adverse events and the balancing act of immunotherapy

2022 219 citations Michael Conroy, Jarushka Naidoo Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Conroy United States	9	252	186	85	55	48	19	464
Jeryl Villadolid United States	4	311 1.2×	97 0.5×	65 0.8×	77 1.4×	50 1.0×	4	398
Philippe Rochigneux France	14	406 1.6×	157 0.8×	97 1.1×	132 2.4×	47 1.0×	39	649
Gary W. Jean United States	7	239 0.9×	80 0.4×	78 0.9×	92 1.7×	35 0.7×	14	375
Sara Falivene Italy	9	315 1.3×	140 0.8×	36 0.4×	137 2.5×	58 1.2×	27	521
Justyna Amelio United Kingdom	13	148 0.6×	75 0.4×	95 1.1×	110 2.0×	31 0.6×	20	486
Thomas Newsom-Davis United Kingdom	12	204 0.8×	128 0.7×	233 2.7×	112 2.0×	47 1.0×	42	516
Yuqin Song China	10	162 0.6×	59 0.3×	87 1.0×	43 0.8×	30 0.6×	66	371
Ricardo Fernandes Canada	12	402 1.6×	75 0.4×	73 0.9×	171 3.1×	45 0.9×	34	531
Peter Bojko Germany	13	181 0.7×	86 0.5×	92 1.1×	58 1.1×	13 0.3×	37	523
Takafumi Minami Japan	15	199 0.8×	151 0.8×	153 1.8×	192 3.5×	31 0.6×	68	572

Countries citing papers authored by Michael Conroy

Since Specialization

Citations

This map shows the geographic impact of Michael Conroy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Conroy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Conroy more than expected).

Fields of papers citing papers by Michael Conroy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Conroy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Conroy. The network helps show where Michael Conroy may publish in the future.

Co-authorship network of co-authors of Michael Conroy

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Conroy. A scholar is included among the top collaborators of Michael Conroy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Conroy. Michael Conroy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Cooper, Alissa J., Andrea Arfè, Michael Conroy, et al.. (2025). Real‐world outcomes of neoadjuvant chemoimmunotherapy in patients with nonsmall cell lung cancer: Predictors of surgery, pathologic complete response, and event‐free survival. Cancer. 131(18). e70081–e70081.

Conroy, Michael, Hazel O’Sullivan, Delwood C. Collins, et al.. (2024). Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors. PubMed. 2(1). 31–31. 9 indexed citations

Cooper, Alissa J., Michael Conroy, Biagio Ricciuti, et al.. (2024). Multi-institution real world analysis of patients with non-small cell lung cancer (NSCLC) treated with standard of care (SOC) neoadjuvant chemo-immunotherapy (chemoIO).. Journal of Clinical Oncology. 42(16_suppl). 8049–8049. 1 indexed citations

Niknafs, Noushin, Michael Conroy, & Valsamo Anagnostou. (2023). Tracing the genetic fingerprints of tumour evolution: The pursuit of identifying mutations with differential weights within the overall tumour mutation burden and their role in therapeutic responses with immune checkpoint blockade. Clinical and Translational Medicine. 13(6). e1287–e1287. 1 indexed citations

Conroy, Michael & Patrick M. Forde. (2023). Advancing neoadjuvant immunotherapy for lung cancer. Nature Medicine. 29(3). 533–534. 5 indexed citations

Conroy, Michael & Jarushka Naidoo. (2022). Immune-related adverse events and the balancing act of immunotherapy. Nature Communications. 13(1). 392–392. 219 indexed citations breakdown →

Conroy, Michael, et al.. (2022). Immune Checkpoint Inhibitors and Palliative Care at the End of Life: An Irish Multicentre Retrospective Study. Journal of Palliative Care. 40(2). 147–151. 5 indexed citations

Conroy, Michael, et al.. (2022). Targeting KRAS in Pancreatic Cancer. Journal of Personalized Medicine. 12(11). 1870–1870. 20 indexed citations

Slattery, Karen, Vanessa Zaiatz-Bittencourt, Michael Conroy, et al.. (2021). TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer. Journal for ImmunoTherapy of Cancer. 9(2). e002044–e002044. 109 indexed citations

10.

Conroy, Michael, et al.. (2021). Emerging RAS-directed therapies for cancer. Cancer Drug Resistance. 4(3). 543–558. 12 indexed citations

11.

Conroy, Michael, Laura C. Murphy, Brian McNamara, & Séamus O’Reilly. (2020). Delayed onset radiation‐induced brachial plexopathy. The Breast Journal. 26(10). 2075–2076. 2 indexed citations

12.

Conroy, Michael, Megan Greally, Owen J. MacEneaney, Conor O’Keane, & John McCaffrey. (2018). Sarcomatoid Carcinoma of the Prostate Presenting in a 44 Year Old. PubMed. 111(9). 825–825. 2 indexed citations

13.

Conroy, Michael, John A. O'Flynn, & Brian Marsh. (2018). Mortality and long-term dialysis requirement among elderly continuous renal replacement therapy patients in a tertiary referral intensive care unit. Journal of the Intensive Care Society. 20(2). 138–143. 13 indexed citations

14.

Conroy, Michael, Mitesh J. Borad, & Alan H. Bryce. (2017). Hypoxia-Activated Alkylating Agents in BRCA1-Mutant Ovarian Serous Carcinoma. Cureus. 9(7). e1517–e1517. 5 indexed citations

15.

Conroy, Michael & Tabitha G. Moe. (2016). Hepatocellular carcinoma in the adult Fontan patient. Cardiology in the Young. 27(2). 407–409. 12 indexed citations

16.

Campbell, Stephen, et al.. (2011). Pemphigoid gestationis: a case report and review of the literature.. PubMed. 88(1). 21–6. 2 indexed citations

17.

Conroy, Michael, et al.. (2008). Painful plaque on the face and ear. Journal of the American Academy of Dermatology. 58(3). 540–541. 1 indexed citations

18.

Vonderheid, Eric C., et al.. (2005). Evidence for Restricted Vβ Usage in the Leukemic Phase of Cutaneous T Cell Lymphoma. Journal of Investigative Dermatology. 124(3). 651–661. 34 indexed citations

19.

Brickner, Philip W., et al.. (1991). Controlling Hospital Readmission of Elderly Persons Living at Home. Home Health Care Services Quarterly. 12(2). 5–16. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact